Zifexim Tablet is a combination antibiotic formulation containing Cefixime 200 mg and Ofloxacin 200 mg, designed for the treatment of a broad spectrum of bacterial infections. Cefixime, a third-generation cephalosporin, exhibits bactericidal activity by inhibiting bacterial cell wall synthesis, making it effective against Gram-positive and Gram-negative organisms. Ofloxacin, a fluoroquinolone antibiotic, acts by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial DNA replication and transcription. The synergistic action of these two agents provides enhanced efficacy against resistant strains and mixed infections. Zifexim is indicated for the management of urinary tract infections, respiratory tract infections, otitis media, gonorrhea, and skin and soft tissue infections caused by susceptible bacteria. It should be administered orally as prescribed by a healthcare professional, with dosage adjusted according to the severity of infection and patient-specific factors such as renal function. Caution is advised in patients with a history of hypersensitivity to cephalosporins or fluoroquinolones, and potential side effects include gastrointestinal disturbances, hypersensitivity reactions, and central nervous system effects. Proper adherence to the prescribed regimen is essential to prevent the development of antibiotic resistance.